Seer, Inc. (NASDAQ: SEER) is a Healthcare company (Biotechnology) with a market capitalization of $81M. The Maz Rating grades it against the other companies in its sector.
Seer, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.46, Seer, Inc. trades at 5.9x sales and 0.4x book value. Over the last twelve months it generated about $14M of revenue and a net loss of $64M. It runs a gross margin of 45.7%, an operating margin of -477.2% and a net margin of -457.9%. It shows return on equity of -27.0%, return on invested capital of -28.2% and a free cash flow yield of -56.9%. On the balance sheet: a debt-to-equity ratio of 0.10 and a current ratio of 16.89. Over the past 52 weeks the share price ranged from $1.42 to $2.38, with a beta of 1.45.
Seer, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 1 Buy, 2 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.